1. Antiatherosclerotic properties of 4-(2,6-dimethylheptyl)-and 4-(2,6,10-trimethylundecyl)benzoic acids and their amides

   • E. P. Serebryakov
   • G. M. Zhdankina
   • L. V. Filatova

   Molecular-Biological Problems of Drug Design and Mechanism of Drug Action Pages: 639 - 644

2. Synthesis and pharmacological properties of 2,3,4-triaminopyridine derivatives

   • T. I. Vozyakova
   • L. M. Alekseeva
   • V. G. Granik

   OriginalPaper Pages: 645 - 649

3. Topochemical models for predicting the activity of α,γ-diketo acids as inhibitors of the hepatitis c virus NS5B RNA-dependent RNA polymerase

   • S. Bajaj
   • S. S. Sambi
   • A. K. Madan

   OriginalPaper Pages: 650 - 654

4. Mode of antifungal activity and synthesis of mixed-ligand complexes

   • H. M. Parekh
   • M. N. Patel

   OriginalPaper Pages: 655 - 659

5. Antioxidant properties of extracts from the above-ground parts of Filipendula ulmaria

   • I. V. Shilova
   • E. A. Krasnov
   • A. N. Lukina

   Medicinal Plants Pages: 660 - 662

6. Regioselective chlorination of 6-(5-methyl-2-oxo-4-imidazolin-4-yl)-6-oxohexanoic acid ethyl ester: A new synthesis of biotin

   • S. I. Zav’yalov
   • L. B. Kulikova
   • A. G. Zavozin

   Drug Synthesis Methods and Manufacturing Technology Pages: 663 - 667

7. Technology and characterization of medicinal polymer films with doxorubicin

   • L. N. Erofeeva
   • E. N. Chigareva
   • V. T. Dudka

   OriginalPaper Pages: 668 - 672

8. Structural stability of perfluorocarbon and phospholipid emulsions on storage

   • I. N. Kuznetsova
   • V. S. Yurchenko

   OriginalPaper Pages: 673 - 677

9. HPLC-based quality control of cytarabine preparations

   • S. I. Marchenko
   • T. V. Trukhacheva
   • A. I. Zhebentyaev

   Structure of Chemical Compounds, Methods of Analysis and Process Control Pages: 678 - 682

10. HPLC determination of the new cardiotropic drug protecor in blood serum of animals

    • S. N. Ptitsina
    • V. I. Bobrov
    • I. I. Miroshnichenko

    OriginalPaper Pages: 683 - 685

11. Developing a method for the quantitative determination of the P-glycoprotein activity marker fexofenadine in blood plasma

    • G. V. Ramenskaya
    • E. A. Skuridina
    • L. M. Krasnykh

    OriginalPaper Pages: 686 - 689

12. Optimization of conditions for TLC screening of phenothiazine derivatives

    • R. A. Klishchenko
    • Z. A. Temerdashev
    • A. V. Udalov

    OriginalPaper Pages: 690 - 693

13. Voltammetric determination of blood angiotensin II level

    • S. V. Terent’eva
    • E. N. Komarova
    • T. I. Andreeva

    OriginalPaper Pages: 694 - 696